Views & Analysis -

Trending

Latest Views & analysis

in Market Access
Why cell therapy manufacture is a team sport
January 6, 2021 Share
X
Why cell therapy manufacture is a team sport
https://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/
in Views & Analysis
2020 in review: Pharma’s progress outside of COVID-19
December 23, 2020 Share
X
2020 in review: Pharma’s progress outside of COVID-19
https://pharmaphorum.com/views-analysis-oncology/2020-review-pharmas-progress-outside-of-covid-19/

The top 5 pharma M&A deals of 2020

The top 5 pharma M&A deals of 2020

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout

X

The top 5 pharma M&A deals of 2020

https://pharmaphorum.com/views-and-analysis/the-top-5-pharma-ma-deals-of-2020/

What HCPs think about COVID-19’s impact on cancer

What HCPs think about COVID-19’s impact on cancer

COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as

X

What HCPs think about COVID-19’s impact on cancer

https://pharmaphorum.com/views-analysis-oncology/what-hcps-think-about-covid-19s-impact-on-cancer-diagnosis-and-treatment/

Sharing experiences to level the healthcare playing field

Sharing experiences to level the healthcare playing field

Amanda Barrell speaks to Alfred Samuels on his experience of prostate cancer and diversifying clinical trials to include

X

Sharing experiences to level the healthcare playing field

https://pharmaphorum.com/views-analysis-oncology/sharing-experiences-to-level-the-healthcare-playing-field/

More Views & Analysis

A history of Pfizer

A history of Pfizer

In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart…

X

A history of Pfizer

https://pharmaphorum.com/sales-marketing/a_history_of_pfizer/

Being part of the conversation: Turning patient engagement to patient centricity

Being part of the conversation: Turning patient engagement to patient centricity

After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is

X

Being part of the conversation: Turning patient engagement to patient centricity

https://pharmaphorum.com/oncology/turning-patient-engagement-to-patient-centricity/

Toxic positivity and grief: The reality of living through cancer

Toxic positivity and grief: The reality of living through cancer

Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient

X

Toxic positivity and grief: The reality of living through cancer

https://pharmaphorum.com/views-analysis-patients/toxic-positivity-and-grief-the-reality-of-living-through-cancer/

The new pharma collaborations driving transformative research in oncology

The new pharma collaborations driving transformative research in oncology

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of

X

The new pharma collaborations driving transformative research in oncology

https://pharmaphorum.com/views-analysis-oncology/the-new-pharma-collaborations-driving-transformative-research-in-oncology/

Clinical decision-making insights for haematologists and oncologists

Clinical decision-making insights for haematologists and oncologists

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such

X

Clinical decision-making insights for haematologists and oncologists

https://pharmaphorum.com/views-analysis-digital/clinical-decision-making-insights-for-haematologists-and-oncologists/

A history of AstraZeneca

A history of AstraZeneca

A look back at AstraZeneca and its roots in the UK and Sweden

X

A history of AstraZeneca

https://pharmaphorum.com/views-analysis-sales-marketing/a_history_of-_astrazeneca/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com